increased glutathione in acute myeloid leukemia α-Ketoglutarate dehydrogenase is a therapeutic vulnerability Chemoresistance of TP53 mutant acute
Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress response Leukemia Metabolism in acute myeloid leukemia: mechanistic insights and therapeutic targets PMC Understanding and Targeting Metabolic Vulnerabilities in Acute Myeloid Leukemia: An Updated Comprehensive Review PMC Role of Glutathione in Cancer: From Mechanisms to Therapies Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia Current Treatment Options in Oncology Springer Nature Link
Pay in 4 interest-free payments of $6.72 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10




